Can we develop new drugs for hypertension?
نویسندگان
چکیده
منابع مشابه
How Can We Develop AAC for Dementia?
Augmentative and alternative communication (AAC) methods are used to support people who have communication problems. Attempts have been made to apply AAC to assist the communication of people with cognitive impairments, including people with dementia. Two systems, CIRCA and Talking Mats, took as their starting points different types of communication situation which are problematic with dementia...
متن کاملCan we develop simple response criteria for slow acting antirheumatic drugs?
The conventional assessment of response to slow acting antirheumatic drugs depends on multiple clinical and laboratory measures. Each measure is analysed separately. For clinical practice and therapeutic trials a single unified classification of response is preferable, based on the most sensitive and simple current measures. Whether or not this was practical was determined in a prospective stud...
متن کاملCan we afford to develop treatments for dementia?
his issue and that of the BMJ (22nd June 2002), are dedicated to neuro-degenerative disorders. We have come a long way in this field over the past two decades or so. Twenty years ago we knew only that Alzheimer's disease (AD) affected many elderly people, segregated in some early onset families, and was predominantly a disorder of cholin-ergic function. Now we have five years of postlicencing e...
متن کاملNew drugs, procedures, and devices for hypertension.
Successful treatment of hypertension is difficult despite the availability of several classes of antihypertensive drug, and the value of strategies to combat the effect of adverse lifestyle behaviours on blood pressure. In this paper, we discuss two promising therapeutic alternatives for patients with resistant hypertension: novel drugs, including new pharmacological classes (such as vasopeptid...
متن کاملPreserving Confidentiality in Ontologies: Can we Develop Secure Ontologies?
Many semantic web applications require selective sharing of ontologies due to copyright, confidentiality, business, security concerns and others. Our motivation is to protect the possibility to infer sensitive information and improperly extract it from the connected knowledge bases represented in ontologies. Supporting the design knowledge bases in order to overcome possible types of attacks. W...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 1982
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1982.tb01348.x